
Erinne R. Dabkowski
Examiner (ID: 9598, Phone: (571)272-1829 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 857 |
| Issued Applications | 384 |
| Pending Applications | 153 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16976201
[patent_doc_number] => 20210220438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => BIOMARKER PANEL FOR MONITORING KIDNEY HEALTH
[patent_app_type] => utility
[patent_app_number] => 17/154824
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154824 | BIOMARKER PANEL FOR MONITORING KIDNEY HEALTH | Jan 20, 2021 | Abandoned |
Array
(
[id] => 18337146
[patent_doc_number] => 20230129095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/792594
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -91
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792594 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | Jan 13, 2021 | Pending |
Array
(
[id] => 18164666
[patent_doc_number] => 20230031262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => TREATMENT OF MILD TRAUMATIC BRAIN INJURY
[patent_app_type] => utility
[patent_app_number] => 17/787848
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787848
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787848 | TREATMENT OF MILD TRAUMATIC BRAIN INJURY | Dec 21, 2020 | Pending |
Array
(
[id] => 18227836
[patent_doc_number] => 20230066830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/787483
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787483 | METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM CELLS | Dec 17, 2020 | Pending |
Array
(
[id] => 18468847
[patent_doc_number] => 20230203129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
[patent_app_type] => utility
[patent_app_number] => 17/786669
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786669
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786669 | ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES | Dec 15, 2020 | Pending |
Array
(
[id] => 18108075
[patent_doc_number] => 20230000955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => THROMBOMODULIN FUNCTIONAL DOMAINS FOR USE IN PROMOTING OSTEOBLAST FUNCTIONS AND BONE HEALING
[patent_app_type] => utility
[patent_app_number] => 17/780976
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780976
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780976 | THROMBOMODULIN FUNCTIONAL DOMAINS FOR USE IN PROMOTING OSTEOBLAST FUNCTIONS AND BONE HEALING | Dec 14, 2020 | Pending |
Array
(
[id] => 18109577
[patent_doc_number] => 20230002457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => PEPTIDES FOR REGULATING GLUCOSE
[patent_app_type] => utility
[patent_app_number] => 17/782869
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782869 | PEPTIDES FOR REGULATING GLUCOSE | Dec 3, 2020 | Pending |
Array
(
[id] => 18109577
[patent_doc_number] => 20230002457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => PEPTIDES FOR REGULATING GLUCOSE
[patent_app_type] => utility
[patent_app_number] => 17/782869
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782869 | PEPTIDES FOR REGULATING GLUCOSE | Dec 3, 2020 | Pending |
Array
(
[id] => 18107928
[patent_doc_number] => 20230000808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => COMPOSITIONS AND METHODS EXCLUDING OR WITH REDUCED GLUTAMINE FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIAS
[patent_app_type] => utility
[patent_app_number] => 17/782376
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782376 | COMPOSITIONS AND METHODS EXCLUDING OR WITH REDUCED GLUTAMINE FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIAS | Dec 3, 2020 | Abandoned |
Array
(
[id] => 18375993
[patent_doc_number] => 20230151075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => PARATHYROID HORMONE ATTENUATES LOW BACK PAIN AND OSTEOARTHRITIC PAIN
[patent_app_type] => utility
[patent_app_number] => 17/781185
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781185
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781185 | PARATHYROID HORMONE ATTENUATES LOW BACK PAIN AND OSTEOARTHRITIC PAIN | Dec 1, 2020 | Pending |
Array
(
[id] => 16868561
[patent_doc_number] => 20210162028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => Methods for Inducing Intermittent Fasting and Modulating Autophagy
[patent_app_type] => utility
[patent_app_number] => 17/247153
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17247153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/247153 | Methods for Inducing Intermittent Fasting and Modulating Autophagy | Dec 1, 2020 | Pending |
Array
(
[id] => 18468813
[patent_doc_number] => 20230203095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => BIOLOGICAL PEPTIDE FOR TREATING LUNG DISEASES AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/778939
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778939 | BIOLOGICAL PEPTIDE FOR TREATING LUNG DISEASES AND APPLICATION THEREOF | Nov 19, 2020 | Pending |
Array
(
[id] => 18468813
[patent_doc_number] => 20230203095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => BIOLOGICAL PEPTIDE FOR TREATING LUNG DISEASES AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/778939
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778939 | BIOLOGICAL PEPTIDE FOR TREATING LUNG DISEASES AND APPLICATION THEREOF | Nov 19, 2020 | Pending |
Array
(
[id] => 16688340
[patent_doc_number] => 20210070816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => SURFACTANT ADHESIVE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/100269
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100269
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/100269 | Surfactant adhesive composition | Nov 19, 2020 | Issued |
Array
(
[id] => 17377044
[patent_doc_number] => 11235033
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-02-01
[patent_title] => Materials and methods for the treatment of vascular calcification
[patent_app_type] => utility
[patent_app_number] => 17/092024
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 32
[patent_no_of_words] => 14091
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092024
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092024 | Materials and methods for the treatment of vascular calcification | Nov 5, 2020 | Issued |
Array
(
[id] => 17052177
[patent_doc_number] => 20210261611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/087597
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087597
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/087597 | HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY | Nov 1, 2020 | Pending |
Array
(
[id] => 17052177
[patent_doc_number] => 20210261611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/087597
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087597
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/087597 | HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY | Nov 1, 2020 | Pending |
Array
(
[id] => 18887753
[patent_doc_number] => 11866515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Hemiasterlin derivatives for conjugation and therapy
[patent_app_type] => utility
[patent_app_number] => 17/087594
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 34932
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/087594 | Hemiasterlin derivatives for conjugation and therapy | Nov 1, 2020 | Issued |
Array
(
[id] => 16913964
[patent_doc_number] => 20210187056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 17/084046
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17084046
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/084046 | METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE | Oct 28, 2020 | Abandoned |
Array
(
[id] => 18056525
[patent_doc_number] => 20220387611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/769709
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -99
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769709 | METHODS FOR TREATING CANCER | Oct 15, 2020 | Pending |